title: Immunogenicity and safety of yeast-derived recombinant hepatitis B vaccine (Heberbiovac HB) in South African children.
authors.forename: M J
authors.initials: MJ
authors.lastname: Mphahlele
authors.forename: R J
authors.initials: RJ
authors.lastname: Burnett
authors.forename: T
authors.initials: T
authors.lastname: Kyaw
authors.forename: H S
authors.initials: HS
authors.lastname: Schoeman
authors.forename: S
authors.initials: S
authors.lastname: Aspinall
mesh_terms: D004334:Drug Administration Schedule; D005260:Female; D006509:Hepatitis B / Q000276:immunology* / Q000517:prevention & control; D017325:Hepatitis B Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology*; D006801:Humans; D017589:Immunization Programs; D007223:Infant; D008297:Male; D013019:South Africa; D019444:Vaccines, DNA / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology*
chemical_list: D017325:Hepatitis B Vaccines; D019444:Vaccines, DNA; C115360:heberbiovac-HB